Emmanuel Papada

Stock Analyst at Barclays

(n/a)

# 4,990

Out of 5,140 analysts

7

Total ratings

n/a

Success rate

-13.95%

Average return

Main Sectors:

Top Industries:

Drug Manufacturers - General

Stocks Rated by Emmanuel Papada

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	NVS Novartis AG	Upgrades: Equal-Weight	n/a	$162.67	-	4	Jan 6, 2026
	AZN AstraZeneca	Upgrades: Hold	n/a	$204.20	-	1	Apr 16, 2024
	SNY Sanofi	Upgrades: Equal-Weight	n/a	$46.76	-	2	Nov 1, 2018

Novartis AG

Jan 6, 2026

Upgrades: Equal-Weight

Price Target: n/a

Current: $162.67

Upside: -

AstraZeneca

Apr 16, 2024

Upgrades: Hold

Price Target: n/a

Current: $204.20

Upside: -

Sanofi

Nov 1, 2018

Upgrades: Equal-Weight

Price Target: n/a

Current: $46.76

Upside: -